Some additional info was provided as follows:
The options vest monthly over 48 months, commencing on September 11, 2014.
Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock at settlement.
25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of August 11, 2014
; and (ii) the first day thereafter during which the issuer's trading window is open.
The RSUs expire 30 days from the date they vest.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever OncoGenex Pharmaceuticals Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
OncoGenex Pharmaceuticals Inc. just filed a General Statement of acquisition of beneficial ownership - Jan. 16, 2015
OncoGenex Pharmaceuticals: Entry Into A Material Definitive Agreement - Dec. 30, 2014